Life Sciences
Asia-Pacific Guide 2025 : Asia-Pacific Region
Band 2
Email address
[email protected]Contact number
02073 490 296About
Provided by DLA Piper LLP
You can learn more about our practice at dlapiper.com.
Chambers Review
DLA Piper maintains a sizeable team with a full life sciences offering which includes coverage of anti-corruption, compliance, clinical trials, IP, regulatory and competition law issues. It is particularly respected for its skilled handling of patent litigation, including infringement, amendment, revocation and enforcement for major pharmaceutical companies. The firm is also noted for its experience handling high-value cross-border transactional matters and commercialisation matters. The team acts for a broad range of biotech, healthcare, pharmaceutical and vaccine companies and has impressive geographical coverage, with offices in Australia, New Zealand, China, Japan, South Korea, Singapore and Thailand.
Nicholas Tyacke and Sammy Fang are main contacts for the life sciences practice, based in Sydney and Hong Kong respectively.
Work Highlights
- DLA Piper advised Pfizer on a regulatory litigation in the Federal Court of Australia under the Gene Technology Act 2000 to halt supply of the Pfizer and Moderna Covid-19 vaccines in Australia.
Strengths
Provided by Chambers
"The DLA team is very thorough and seeks to think through every possible issue."
"The firm excels at navigating complex legal matters with precision and expertise. It is a team of seasoned attorneys that combines in-depth knowledge of the law with strategic thinking."
"The DLA team is very thorough and seeks to think through every possible issue."
"The firm excels at navigating complex legal matters with precision and expertise. It is a team of seasoned attorneys that combines in-depth knowledge of the law with strategic thinking."